Author

Herbert L. Bonkovsky

EFFICACY AND SAFETY OF GIVOSIRAN IN PATIENTS WITH ACUTE HEPATIC PORPHYRIA: 24-MONTH INTERIM ANALYSIS OF THE PHASE 3 ENVISION RANDOMIZED CLINICAL TRIAL
EFFICACY AND SAFETY OF GIVOSIRAN IN PATIENTS WITH ACUTE HEPATIC PORPHYRIA: 24-MONTH INTERIM ANALYSIS OF THE PHASE 3 ENVISION RANDOMIZED CLINICAL TRIAL

Herbert L. Bonkovsky  et al.

EFFICACY AND SAFETY OF GIVOSIRAN IN PATIENTS WITH ACUTE HEPATIC PORPHYRIA: 24-MONTH INTERIM ANALYSIS OF THE PHASE 3 ENVISION RANDOMIZED CLINICAL TRIAL
EFFICACY AND SAFETY OF GIVOSIRAN IN PATIENTS WITH ACUTE HEPATIC PORPHYRIA: 24-MONTH INTERIM ANALYSIS OF THE PHASE 3 ENVISION RANDOMIZED CLINICAL TRIAL

EXPLORE PART B: A PROSPECTIVE, INTERNATIONAL, LONG-TERM NATURAL HISTORY STUDY OF PATIENTS WITH ACUTE HEPATIC PORPHYRIA WITH RECURRENT SYMPTOMS
EXPLORE PART B: A PROSPECTIVE, INTERNATIONAL, LONG-TERM NATURAL HISTORY STUDY OF PATIENTS WITH ACUTE HEPATIC PORPHYRIA WITH RECURRENT SYMPTOMS

Herbert L. Bonkovsky  et al.

Item 1 - 3 / 3
1